Putting Perspective on New AUC for ICD and CRT
The recent release of appropriate use criteria (AUC) for use of implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy comes at a time of heightened scrutiny of ICD implantation, according to a new perspective piece published in the Journal of the American Medical Association.
The new criteria seek to guide appropriate care and improve care and health outcomes by enhancing physician and patient decision making, Mitka notes. He quotes Andrea M. Russo, MD, FACC, a member of the AUC for ICD and CRT technical panel, who said the criteria are designed to reflect real life. "Guidelines present broader recommendations, but in real life, patients are different, with different comorbidities that may not be covered by guidelines," she said.
Alan Kadish, MD, FACC, who was also interviewed for the article, said the new criteria are "superb" in that they break down syndromes in detail. "It allows for clinical judgment," he said. "Rather than just saying yes or no, it provides three levels of appropriateness and scoring, allowing clinicians to tailor their therapy to individual patients."
Clinical Topics: Arrhythmias and Clinical EP, Cardiac Surgery, Congenital Heart Disease and Pediatric Cardiology, Heart Failure and Cardiomyopathies, Invasive Cardiovascular Angiography and Intervention, Implantable Devices, SCD/Ventricular Arrhythmias, Cardiac Surgery and Arrhythmias, Cardiac Surgery and CHD and Pediatrics, Cardiac Surgery and Heart Failure, Congenital Heart Disease, CHD and Pediatrics and Arrhythmias, CHD and Pediatrics and Interventions, CHD and Pediatrics and Quality Improvement, Acute Heart Failure
Keywords: Down Syndrome, Decision Making, Heart Failure, Comorbidity, Coronary Artery Bypass, Defibrillators, Implantable, United States, Cardiac Resynchronization Therapy
< Back to Listings